An interventional study of PG and CTRL in Shoulder Pain, sponsored by University of Padova. Completed at 1 site in Italy. Open to participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-02-08.
Sponsored by University of Padova · Not applicable, Interventional, and Treatment
Digital therapy may provides real time visual feedbacks. Instrumented devices objectively quantify the patient's performance during rehabilitation and thus could be helpful for the personalization of the exercises.
The interactive ball of this trial allows measuring both movement and pressure applied on it. Therefore, the objectives of this study are: (i) to evaluate whether the use of a novel digital therapy gaming system was therapeutically relevant during shoulder rehabilitation; (ii) to understand whether the device was effective in improving patients' engagement in comparison to a control non-gaming rehabilitation program.
707 studies on the registry are indexed under Shoulder Pain; 152 are open to participants now.
This study's enrollment of 22 is below the median of 60 across 561 interventional studies indexed under Shoulder Pain.
Browse Shoulder Pain studies →University of Padova is the lead sponsor of 210 studies on the registry; 42 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Behavioral: PG
Behavioral: CTRL
Shoulder Digital therapy
Shoulder non-digital therapy
shoulder pain
Shoulder pain by means of Visual Analogue Scale (no pain:0; maximal pain: 10)
Time frame: From baseline up to two weeks
shoulder strength
Shoulder strength by means of an isometric maximal voluntary contraction measured in kilograms
Time frame: From baseline up to two weeks
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Padova